The extracellular regulation of growth factor action.
暂无分享,去创建一个
[1] R. Ross,et al. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences , 1992, The Journal of cell biology.
[2] J. Gabrilove,et al. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan , 1991, The Journal of cell biology.
[3] C. Brannan,et al. Requirement for mast cell growth factor for primordial germ cell survival in culture , 1991, Nature.
[4] S. Aaronson,et al. A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. , 1991, Genes & development.
[5] D. Williams,et al. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Sporn,et al. Cytokines in context , 1991, The Journal of cell biology.
[7] Y. Kita,et al. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. , 1991, Journal of Immunology.
[8] G. Giménez-Gallego,et al. Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. , 1991, The Journal of biological chemistry.
[9] P. Leder,et al. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.
[10] Erkki Ruoslahti,et al. Proteoglycans as modulators of growth factor activities , 1991, Cell.
[11] J. Massagué,et al. Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Klagsbrun,et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.
[13] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[14] D. Rifkin,et al. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Levinson,et al. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1 , 1990, The Journal of experimental medicine.
[16] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.
[17] G. Duff,et al. A soluble form of the interleukin‐1 receptor produced by a human B cell line , 1990, FEBS letters.
[18] C. March,et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms , 1990, Cell.
[19] M. Feldmann,et al. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Brody,et al. PDGF‐stimulated fibroblast proliferation is enhanced synergistically by receptor‐recognized α2‐Macroglobulin , 1990, Journal of cellular physiology.
[21] C. W. Rettenmier,et al. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. , 1990, Blood.
[22] Austin G Smith,et al. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage , 1990, Cell.
[23] D. Johnson,et al. Diverse forms of a receptor for acidic and basic fibroblast growth factors , 1990, Molecular and cellular biology.
[24] A. Paterson,et al. Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases , 1990, Molecular and cellular biology.
[25] D. Rifkin,et al. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system , 1990, The Journal of cell biology.
[26] E. Ruoslahti,et al. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.
[27] L. Gentry,et al. The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. , 1990, Biochemistry.
[28] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[29] B. Schryver,et al. Secreted int-1 protein is associated with the cell surface. , 1990, Molecular and cellular biology.
[30] C. Disteche,et al. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity , 1990, Molecular and cellular biology.
[31] J. Massagué,et al. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Sporn,et al. Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin. , 1990, The Journal of biological chemistry.
[33] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[34] H. Moses,et al. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.
[35] T. Nakamura,et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Betsholtz,et al. Analogous alternative splicing , 1990, Nature.
[37] D. Rifkin,et al. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. , 1990 .
[38] K. Miyazono,et al. Latent form of transforming growth factor-beta 1 acts as a potent growth inhibitor on a human erythroleukemia cell line. , 1990, Biochemical and biophysical research communications.
[39] E. Chambaz,et al. Transforming growth factor-beta stimulates the expression of alpha 2-macroglobulin by cultured bovine adrenocortical cells. , 1990, The Journal of biological chemistry.
[40] L. Bonewald,et al. Characterization of the latent transforming growth factor ß complex in Bone , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[42] D. Wallach,et al. Soluble cytokine receptors are present in normal human urine , 1989, Journal of Experimental Medicine.
[43] Alan I. Alpert,et al. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.
[44] D. Wallach,et al. Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.
[45] D. Simon,et al. cDNA sequence and chromosomal localization of the mouse parvalbumin gene, Pva. , 1989, Genetical research.
[46] J. Downing,et al. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms , 1989, Molecular and cellular biology.
[47] D. Rifkin,et al. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.
[48] B. Mroczkowski,et al. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity , 1989, Molecular and cellular biology.
[49] F. Welt,et al. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex , 1989, The Journal of cell biology.
[50] P. Jullien,et al. Acidic cellular environments: Activation of latent tgf‐β and sensitization of cellular responses to tgf‐β and egf , 1989 .
[51] D. Rifkin,et al. Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. , 1989, The Journal of biological chemistry.
[52] L. Bonewald,et al. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. , 1989, Biochemical and biophysical research communications.
[53] J. Massagué,et al. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction , 1989, Cell.
[54] J. Wagner,et al. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐life , 1989, Journal of cellular physiology.
[55] T. Hirano,et al. Identification of alpha 2-macroglobulin as a carrier protein for IL-6. , 1989, Journal of immunology.
[56] D. Rifkin,et al. Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan , 1989, Journal of cellular physiology.
[57] D. Rifkin,et al. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.
[58] H. Moses,et al. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium , 1988, The Journal of cell biology.
[59] R. Friesel,et al. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. , 1988, Biochemical and biophysical research communications.
[60] E. Appella,et al. Structure and function of epidermal growth factor‐like regions in proteins , 1988, FEBS letters.
[61] R Guillemin,et al. Receptor- and heparin-binding domains of basic fibroblast growth factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Dexter,et al. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.
[63] E Ruoslahti,et al. New perspectives in cell adhesion: RGD and integrins. , 1987, Science.
[64] M. O’Connor-McCourt,et al. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.
[65] D. Moscatelli,et al. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.
[66] R. Derynck,et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.
[67] D. Gospodarowicz,et al. Heparin protects basic and acidic FGF from inactivation , 1986, Journal of cellular physiology.
[68] M. Czech,et al. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. , 1986, The Journal of biological chemistry.
[69] E. Froesch,et al. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. , 1986, The Journal of clinical investigation.
[70] Anita B. Roberts,et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.
[71] I. Kerr,et al. Purification and characterization of vaccinia virus growth factor , 1985, Cell.
[72] S. Aaronson,et al. The v‐sis/PDGF‐2 transforming gene product localizes to cell membranes but is not a secretory protein. , 1985, The EMBO journal.
[73] R. Nusse,et al. Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact , 1984, Cell.
[74] E. Chen,et al. Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.
[75] F. Ito,et al. Transmembrane delivery of polypeptide growth factors bypassing the intrinsic cell surface receptors: synthesis and biological activity of a conjugate of epidermal growth factor with alpha 2-macroglobulin. , 1984, Cell structure and function.
[76] J. Spiess,et al. Production of an epidermal growth factor receptor-related protein. , 1984, Science.
[77] E. Levine,et al. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.
[78] A. Ullrich,et al. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor , 1983, Nature.
[79] D. Clemmons,et al. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. , 1983, Journal of Clinical Endocrinology and Metabolism.
[80] G. Smith,et al. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[81] M. Sporn,et al. Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.
[82] P. A. Peterson,et al. Nerve growth factor binds to serum alpha-2-macroglobulin. , 1979, Biochemical and biophysical research communications.
[83] S. W. Hall,et al. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. , 1991, The Journal of clinical investigation.
[84] M. Sporn,et al. The Multifunctional Nature of Peptide Growth Factors , 1991 .
[85] K. Miyazono,et al. TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. , 1990, Cell.
[86] R. Hintz. Role of growth-hormone and insulin-like growth-factor-binding proteins. , 1990, Hormone research.
[87] M. Sporn,et al. Sandwich Enzyme-Linked Immunosorbent Assays (Selisas) Quantitate and Distinguish Two Forms of Transforming Growth Factor-Beta (TGF-β1 and TGF-β2) in Complex Biological Fluids , 1989 .
[88] P. Hauschka,et al. Polypeptide growth factors in bone matrix. , 1988, Ciba Foundation symposium.
[89] T. Deuel,et al. Specific covalent binding of platelet-derived growth factor to human plasma alpha 2-macroglobulin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[90] E. Chen,et al. Human transforming growth factor-alpha: precursor structure and expression in E. coli. , 1984, Cell.
[91] E. Froesch,et al. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. , 1977, The Journal of clinical endocrinology and metabolism.
[92] S. Nissley,et al. The serum half-life of somatomedin activity: evidence for growth hormone dependence. , 1976, Acta Endocrinologica.